Citi analyst Peter Verdult downgraded Genmab A/S (NASDAQ: GMAB) from Buy to Neutral.The analyst commented, "With the shares trading near ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE